Description
Eczemus (Tacrolimus) Ointment 0.03% is indicated for short-term and intermittent long-term therapy in the treatment of moderate to severe atopic dermatitis (eczema) in children.
Additional information
| brand | Brookes Pharmaceutical Labs |
|---|
| brand | Brookes Pharmaceutical Labs |
|---|
